Use App
Trending
News
Earnings
Newsletters
Work With Us
All
DIA
0.51%
SPY
0.11%
QQQ
0.00%
Trending
SLV
1.38%
OMER
73.46%
DOT
1.50%
PPLT
2.19%
ENB
0.07%
SIVR
0.84%
SPXL
0.50%
RCAT
0.54%
ECL
0.42%
JEPQ
0.20%
SLV
1.38%
OMER
73.46%
DOT
1.50%
PPLT
2.19%
ENB
0.07%
SIVR
0.84%
SPXL
0.50%
RCAT
0.54%
ECL
0.42%
JEPQ
0.20%
home
Symbol
CNSP
CNSP
Cns Pharmaceuticals Inc
7,739
Mkt Cap
$3.85M
Volume
42,189.00
52W High
$114.00
52W Low
$4.93
PE Ratio
-0.11
CNSP Fundamentals
Price
$6.20
Prev Close
$6.23
Open
$6.15
50D MA
$7.25
Beta
0.98
Avg. Volume
14,412.53
EPS (Annual)
-$466.44
P/B
0.36
Rev/Employee
$0.00
PE Ratio
-0.11
Loading...
Loading...
Feed
News
Sentiment
Fundamentals
Info
News
all
press releases
CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved
The company intends to commence the phase 2 study of its lead program, TPI 287, to treat Glioblastoma Multiforme (GBM) by year-end.
Stocktwits
·
7mo ago
Full Article
<
...
1
>
Latest CNSP News
View
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile